Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
Inavolisib leads to significantly longer progression-free survival, with no increase seen in incidence of toxic events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.